Nutex Health Inc.
Nutex Health Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 20,184 | 8.1 | 3.55 | 0.69 | 19,461.96 |
| Oct 2026 | 20,413 | 7.8 | 3.42 | 0.69 | 18,696.11 |
| Oct 2026 | 20,293 | 8.3 | 3.49 | 0.69 | 19,068.18 |
| Oct 2026 | 20,747 | 7.4 | 3.23 | 0.69 | 17,626.45 |
| Oct 2026 | 18,588 | 7.6 | 3.32 | 0.69 | 18,133.63 |
| Oct 2026 | 18,349 | 7.9 | 3.46 | 0.69 | 18,867.51 |
| Oct 2026 | 18,392 | 7.8 | 3.43 | 0.69 | 18,690.38 |
| Oct 2026 | 18,130 | 8.2 | 3.58 | 0.69 | 19,453.00 |
Nutex Health Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 210,752,000.0 | 216,485,000.0 | 151,679,000.0 | 267,804,000.0 |
| Net Profit | 65,842,000.0 | 46,807,000.0 | 11,834,000.0 | 55,435,000.0 |
| EPS | 9.6 | 6.7 | — | 8.3 |
Nutex Health Inc. Revenue & Profit: Last 4 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 875,257,000.0 | 479,949,000.0 | 247,646,000.0 | 219,294,306.0 |
| Net Profit | 70,789,000.0 | 52,097,000.0 | -45,787,000.0 | -424,780,446.0 |
| EPS | 11.1 | 10.2 | -10.5 | -100.5 |
Nutex Health Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 918,525,000.0 | 655,320,000.0 | 398,245,497.0 | 431,751,985.0 | — |
| Total Liabilities | 495,088,000.0 | 466,787,000.0 | 319,139,391.0 | 311,424,585.0 | — |
| Total Equity | 329,447,000.0 | 132,439,000.0 | 61,453,190.0 | 95,862,701.0 | — |
Owes vs Owns
Nutex Health Inc. owed $0.47 for every $1 it owned in Jun 2026, down from $0.72 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.47× | 0.54× | 0.71× | 0.80× | 0.72× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Nutex Health Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
How it's funded — Dec 2025
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 185.6 | 40.6 | 22.0 | 34.3 |
| Receivables | 325.4 | 236.1 | 62.8 | 58.3 |
| Inventory | 2.9 | 2.9 | 3.4 | 3.5 |
| Fixed assets (tangible) | 343.9 | 324.7 | 269.4 | 295.2 |
| Intangible assets | 35.1 | 29.4 | 37.6 | 38.2 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 25.6 | 21.6 | 3.1 | 2.3 |
| Liabilities & equity | ||||
| Short-term debt | 14.1 | 17.9 | 14.2 | 15.2 |
| Long-term debt | 29.2 | 22.5 | 26.3 | 23.1 |
| Payables | 49.0 | 10.4 | 25.3 | 27.5 |
| Other liabilities | 402.9 | 416.0 | 253.4 | 245.7 |
| Shareholders' equity | 423.4 | 188.5 | 79.1 | 120.3 |
| Net tangible assets | 294.3 | 103.0 | 23.9 | 57.7 |
Nutex Health Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 248,125,000.0 | 23,153,000.0 | 1,257,000.0 | 50,607,108.0 | — |
| Investing Activities | -5,242,000.0 | -5,606,000.0 | -11,240,000.0 | -4,337,398.0 | — |
| Financing Activities | -97,949,000.0 | 1,091,000.0 | -2,270,000.0 | -48,132,730.0 | — |